Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         Center for Scientific Review Special Emphasis Panel PAR Panel: Biodata Management and Common Fund Data Sets.                    

*Date:*                         November 19-20, 2024.                    

*Time:*                         9:00 a.m. to 6:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Address:*                         National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.                    

*Meeting Format:*                         Virtual Meeting.                    

*Contact Person:*                         Janice Duy, Ph.D., Scientific Review Officer, Center for Scientific Review, 6701 Rockledge Drive, Bethesda, MD 20892, 301-594-3139,                         *janice.duy@nih.gov.*

*Name of Committee:*                         Social and Community Influences on Health Integrated Review Group Population and Public Health Approaches to HIV/AIDS Study Section.                    

*Date:*                         November 19-20, 2024.                    

*Time:*                         9:00 a.m. to 6:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Address:*                         National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.                    

*Meeting Format:*                         In Person and Virtual Meeting.                    

*Contact Person:*                         Aubrey S. Madkour, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 1000C, Bethesda, MD 20892, (301) 594-6891,                         *madkouras@csr.nih.gov.*

*Name of Committee:*                         Center for Scientific Review Special Emphasis Panel; The Cancer Drug Development and Cancer Therapeutics.                    

*Date:*                         November 19, 2024.                    

*Time:*                         10:00 a.m. to 6:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Address:*                         National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.                    

*Meeting Format:*                         Virtual Meeting.                    

*Contact Person:*                         Lambratu Rahman Sesay, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6214, MSC 7804, Bethesda, MD 20892, 301-905-8294,                         *rahman-sesay@csr.nih.gov.*

*Name of Committee:*                         Center for Scientific Review Special Emphasis Panel PAR Panel: Advancing HIV Service Delivery Through Pharmacies and Pharmacists.                    

*Date:*                         November 20-21, 2024.                    

*Time:*                         9:00 a.m. to 6:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Address:*                         National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.                    

*Meeting Format:*                         Virtual Meeting.                    

*Contact Person:*                         Mark P. Rubert, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5218, MSC 7852, Bethesda, MD 20892, 301-806-6596,                         *rubertm@csr.nih.gov.*

*Name of Committee:*                         Center for Scientific Review Special Emphasis Panel Member Conflict: Musculoskeletal Sciences.                    

*Date:*                         November 20, 2024.                    

*Time:*                         9:30 a.m. to 6:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Address:*                         National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.                    

*Meeting Format:*                         Virtual Meeting.                    

*Contact Person:*                         Chee Lim, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4128 Bethesda, MD 20892, (301) 435-1850,                         *limc4@csr.nih.gov.*

*Name of Committee:*                         Center for Scientific Review Special Emphasis Panel PAR-22-180: Maximizing Investigators' Research Award (R35).                    

*Date:*                         November 20-21, 2024.                    

*Time:*                         9:30 a.m. to 6:30 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Address:*                         National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.                    

*Meeting Format:*                         Virtual Meeting.                    

*Contact Person:*                         Mufeng Li, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (240) 507-9155,                         *mufeng.li@nih.gov.*

*Name of Committee:*                         Center for Scientific Review Special Emphasis Panel Member Conflict: Cellular Signaling and Aging.                    

*Date:*                         November 20, 2024.                    

*Time:*                         10:00 a.m. to 6:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Address:*                         National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.                    

*Meeting Format:*                         Virtual Meeting.                    

*Contact Person:*                         Robert O'Hagan, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD, 20892 (240) 909-6378,                         *ohaganr2@csr.nih.gov.*

*Name of Committee:*                         Infectious Diseases and Immunology B Integrated Review Group Immunobiology of Transplantation and Alloimmunity Study Section.                    

*Date:*                         November 20-21, 2024.                    

*Time:*                         10:00 a.m. to 6:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Address:*                         National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.                    

*Meeting Format:*                         Virtual Meeting.                    

*Contact Person:*                         Anthony David Foster, Scientific Review Officer, The Center for Scientific Review, The National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 496-3297,                         *anthony.foster@nih.gov.*

*Name of Committee:*                         Center for Scientific Review Special Emphasis Panel Member Conflict: Pain Mechanisms.                    

*Date:*                         November 20, 2024.                    

*Time:*                         2:00 p.m. to 6:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Address:*                         National Institutes of Health, Rockledge II, 6701 Rockledge, Drive Bethesda, MD 20892.                    

*Meeting Format:*                         Virtual Meeting.                    

*Contact Person:*                         Kirk Thompson, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5184, MSC 7844, Bethesda, MD 20892, 301-435-1242,                         *kgt@mail.nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, National Institutes of Health, HHS)

Dated: October 23, 2024.

Miguelina Perez, 

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2024-24977 Filed 10-25-24; 8:45 am]

BILLING CODE 4140-01-P